As on Thursday, Incyte Corp (NASDAQ: INCY) started slowly as it slid -4.21% to $105.92, before settling in for the price of $110.57 at the close. Taking a more long-term approach, INCY posted a 52-week range of $53.56-$112.29.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -40.36%. Meanwhile, its Annual Earning per share during the time was -40.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 524.20%. This publicly-traded company’s shares outstanding now amounts to $196.13 million, simultaneously with a float of $194.31 million. The organization now has a market capitalization sitting at $20.79 billion. At the time of writing, stock’s 50-day Moving Average stood at $101.23, while the 200-day Moving Average is $80.05.
Incyte Corp (INCY) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Incyte Corp’s current insider ownership accounts for 1.03%, in contrast to 103.83% institutional ownership. According to the most recent insider trade that took place on Jan 07 ’26, this organization’s EVP, Head of US Oncology sold 10,856 shares at the rate of 109.07, making the entire transaction reach 1,184,064 in total value, affecting insider ownership by 66,132. Preceding that transaction, on Jan 05 ’26, Company’s EVP & Chief Medical Officer sold 15,634 for 101.70, making the whole transaction’s value amount to 1,589,978. This particular insider is now the holder of 34,203 in total.
Incyte Corp (INCY) Earnings and Revenue Records
Incyte Corp’s EPS increase for this current 12-month fiscal period is 524.20% and is forecasted to reach 7.78 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 105.38% through the next 5 years, which can be compared against the -40.36% growth it accomplished over the previous five years trading on the market.
Incyte Corp (NASDAQ: INCY) Trading Performance Indicators
Let’s observe the current performance indicators for Incyte Corp (INCY). It’s Quick Ratio in the last reported quarter now stands at 3.13. Alongside those numbers, its PE Ratio stands at $17.77, and its Beta score is 0.83. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.32. Similarly, its price to free cash flow for trailing twelve months is now 17.37.
In the same vein, INCY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 5.96, a figure that is expected to reach 1.93 in the next quarter, and analysts are predicting that it will be 7.78 at the market close of one year from today.
Technical Analysis of Incyte Corp (INCY)
Through scrutinizing the latest numbers posted by the [Incyte Corp, INCY], it can be observed that its last 5-days Average volume of 3.0 million was better the volume of 3.0 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 78.83% While, its Average True Range was 60.74.
Raw Stochastic average of Incyte Corp (INCY) in the period of the previous 100 days is set at 79.58%, which indicates a major rise in contrast to 58.31% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.14 that was higher than 2.75 volatility it exhibited in the past 100-days period.
